-
The Indonesian Automotive Industry Association (Gaikindo) raised its target for Indonesia's car exports (completely built up units, or, CBU) to 220,000 vehicles in 2016. This figure implies Gaikindo targets to see a 6 percent (y/y) increase in car exports from 207,691 units last year. Gaikindo Chairman Jongkie Sugiarto said the global economy has started to stabilize and this should have a positive effect on Indonesia's car shipments.
Read column ›
-
Grab, the Malaysia-founded online application used for transportation services, has experienced remarkable growth in Indonesia during the first half of 2016. GrabCar and GrabBike have grown some 250 percent despite a 50 percent cut in its fare subsidy in this period. More than 25 percent of active Grab users in Indonesia use Grab services more than once a month. This success is due to the government's decision to legalize mobile application-based transportation services (under specific conditions) and the re-branding of Grab (formerly it was known as GrabTaxi).
Read column ›
-
AKR Corporindo, one of Indonesia's leading providers of integrated supply chain solutions and particularly known for being a petroleum and basic chemicals trader, can take advantage of a recent government decision that allows the company to construct power plants to supply energy to its tenants at its Java Integrated Industrial and Port Estate (JIIPE) in Gresik (East Java), one of the larger industrial estates in the archipelago. Through these future energy sales, AKR Corporindo is to generate additional income.
Read column ›
-
State-controlled pharmaceutical company Kimia Farma is expected to show steadily improving corporate earnings in the years ahead supported by Indonesia's universal healthcare scheme (in Indonesian: Jaminan Kesehatan Nasional or JKN) that was implemented by the social security agency Badan Penyelenggara Jaminan Sosial Kesehatan (BPJS) in early 2014. The scheme aims to provide all Indonesian citizens with access to a wide range of health services. Obviously, local pharmaceutical companies are in a great position to benefit from this program.
Read column ›
7013700470016997
The views expressed in these business columns are the views of the authors or the interviewed persons only and therefore do not necessarily reflect the views of Indonesia Investments. The authors are free to ventilate their opinions about the Indonesian business climate. Facts presented in these columns are the result of the author's own research or indicated sources, read disclaimer.
